RSS   Newsletter   Contact   Advertise with us
Post Online Media

Juniper names Jeffrey Young as CFO

Jeffrey YoungJuniper Pharmaceuticals, Inc., a women's health therapeutics company, appoints Jeffrey Young as chief financial officer, treasurer and secretary, effective January 1, 2017.

Mr. Young brings over 20 years of financial leadership in the life sciences sector to Juniper. He most recently served as Chief Financial Officer and Treasurer of OvaScience, a global fertility company focused on new treatment options for women.

Article continues below

READ MORE Juniper appoints Alicia Secor president and CEO

During his two-year tenure at OvaScience, Mr. Young led the company's fundraising efforts and international tax strategy.

He was previously the Chief Financial Officer and Treasurer of Transmedics, a developer of medical devices for the maintenance and transport of organs between donors and recipients.

Before that, Mr. Young served as Chief Financial Officer and Treasurer at Lantheus Medical Imaging, where he led and managed multiple debt offerings.

He joined Lantheus from Critical Therapeutics, where he was Chief Accounting Officer.

Early in his career, he worked in various finance roles at PerkinElmer, Inc., and PriceWaterhouseCoopers LLP.

Mr. Young is a Certified Public Accountant and holds a B.S. in Business Administration from Georgetown University.

He will succeed George O. Elston, the Company's outgoing Chief Financial Officer, Treasurer and Secretary, who will be stepping down at the end of the year.




What to read next



 LATEST MOVES FROM Massachusetts 


 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy